Investigation on the effectiveness inhalation aromatherapy with Lavender essential oil versus placebo on the anxiety of patients with burns. a double blinded randomized clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013042413110N1

Enrollment

Registered

2015-06-27

Start date

2015-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Burns. Condition 2: Anxiety. Burns involving 20-29% of body surface, Burns involving 30-39% of body surface, Burns involving 40-49% of body surface, Burns involving 50-59% of body surface, Burns involving 60-69% of body surface Any other mood disorders that do not justify classification to F30-F34, because they are not of sufficient severity or duration

Interventions

Intervention 1: the patients for 20 minutes inhale 2 drops of Lavender essential oil 2% produced by Hyrad Company which was poured on to 10×10 cm gauze attached to collar of patients' shirt. The anxi

Treatment - Drugs

Placebo

the patients for 20 minutes inhale 2 drops of Lavender essential oil 2% produced by Hyrad Company which was poured on to 10×10 cm gauze attached to collar of patients' shirt. The anxiety of the patie

for 20 minutes patients inhale 2 drops of distilled water as placebo which was poured on to 10×10 cm gauze attached to collar of patients' shirt. The anxiety of the patients will be controlled again 2

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 18 to 65 years; burns degree of 2 or 2 and 3 with 15 to 60 percent burn level; stability of hemodynamic status; lack of inhalation burns; lack of allergy or respiratory diseases; lack of narcotic addiction or drug abuse. Exclusion criteria: Lack of patient cooperation during the intervention for any reason; creation dangerous conditions of disease during the intervention; allergy to inhalation of Lavender Essential Oil during the intervention.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Anxiety. Timepoint: Before and 20 minutes after inhalation of lavender (experimental group) or distilled water (control group) for three consecutive nights. Method of measurement: Spielberger questionnaire.	—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026